Abstract:This type of disease has benefited considerably, over recent decades, from progress in ultrasound technique and new methods of medical and surgical treatment. The aetiologies of mitral incompetence can be classified into 4 categories according to their mechanism: 1. Mutilating valve lesions, usually secondary to bacterial endocarditis, but sometimes secondary to trauma (percutaneous valvuloplasty). 2. Rupture of chordae tendineae, either spontaneous or bacterial, in a context of pre-existing valvular heart disease, usually degenerative. 3. Papillary muscle lesions, usually corresponding to rupture of a papillary muscle or the head of a papillary muscle, associated with myocardial infarction. 4. Biological or mechanical valve prosthesis dysfunction. The consequences of acute mitral incompetence depend on its aetiology and the presence or absence of previous mitral valve disease. Three factors determine the clinical presentation and prognosis: the volume of regurgitation, left ventricular function and left atrial compliance. In pure forms, such as those occurring after rupture of chordae tendineae, the haemodynamic profile consists of a marked elevation of left ventricular filling pressures, left atrial mean and systolic pressures (large V wave), and a reduction of the cardiac output. The left ventricular end-diastolic volume is moderately increased, while the end-systolic volume is normal or decreased and the ejection fraction is increased. The clinical picture is that of acute left ventricular failure with a systolic murmur of mitral regurgitation and a pulmonary hypertension syndrome. The absence of left ventricular hypertrophy on the electrocardiogram and the absence of left-sided dilatation on radiological examination indicate the recent nature of the haemodynamic disturbances. The diagnosis of acute IM is confirmed by Doppler ultrasound, which defines the mechanism and sometimes eliminates the need for an invasive investigation. The clinical course depends on the aetiology, the volume of regurgitation, left ventricular function and the treatment implemented. First-line treatment must include vasodilators. Sodium nitroprussate infusion decreases the left ventricular end-diastolic volume and the volume of regurgitation and increases the cardiac output. It allows a rapid reduction of pulmonary artery and capillary hypertension. When this treatment is not sufficient, intra-aortic counterpulsation may be useful. Emergency surgery is sometimes necessary, but usually after improvement of the haemodynamic state by vasodilators. Depending on the aetiology, surgery may consist of valve replacement or surgical repair, which can give excellent results even in the presence of active bacterial endocarditis. In other cases, following control of the acute phase by medical treatment, mitral incompetence will become chronic.

Management of Severe Mitral Regurgitation in Patients With Acute Myocardial Infarction: JACC Focus Seminar 2/5

Ischemic mitral regurgitation: intraventricular papillary muscle imbrication without mitral ring during left ventricular restoration

Acute mitral regurgitation with and without acute heart failure

Surgical Management of Severe Ischaemic Mitral Regurgitation

[Acute mitral valve insufficiency]

The role of surgery for secondary mitral regurgitation and heart failure in the era of transcatheter mitral valve therapies

Postmyocardial Infarction Ventricular Aneurysm: JACC Focus Seminar 5/5

Case Report: Transcatheter Edge-to-edge Repair with MitraClip for Acute Mitral Regurgitation after Myocardial Infarction.

[Early surgical outcomes of coronary heart disease with severe ischemic mitral regurgitation]

Surgery Treatment of Chronic Moderate Ischemic Mitral Regurgitation in Coronary Artery Disease

[Percutaneous treatment of post-acute myocardial infarction mechanical complications: state of the art]

Secondary Mitral Regurgitation: Updated Review with Focus on Percutaneous Interventional Management

Ischemic functional mitral regurgitation: from pathophysiological concepts to current treatment options. A systemic review for optimal strategy

Feasibility of the transcatheter mitral valve repair for patients with severe mitral regurgitation and endangered heart failure

Mitral regurgitation surgery in heart failure due to ischemic cardiomyopathy: a 24-year experience

Outcomes in Degenerative Mitral Regurgitation: Current State-of-the Art and Future Directions

Transcatheter edge‐to‐edge repair in papillary muscle injury complicating acute myocardial infarction

Managing the patient undergoing transcatheter aortic valve replacement with ongoing mitral regurgitation

Systolic anterior motion-mediated mitral regurgitation and surgical management in hypertrophic obstructive cardiomyopathy

Noncardioplegic surgery for ischemic mitral regurgitation

Current Status of Catheter-Based Treatment of Mitral Valve Regurgitation